Delivery Order SPE2DB22D9309-SPE2DB24FAE31
Award Date 1/8/24
Potential Completion Date 1/30/24
Potential Value $7.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to supply NEXPLANON 68 MG IMPLANTS. The order has a potential value of $2,858.76 and a completion date of January 30, 2024. This delivery order is issued against a larger indefinite delivery contract with DLA Troop Support Medical to provide various pharmaceutical and medical supplies to support military treatment facilities worldwide....
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order valued at $17,093.50 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the procurement of 68 mg NEXPLANON contraceptive implants. This delivery order falls under a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with DLA to provide a variety of pharmaceutical and medical supplies to military treatment facilities worldwide. The contract has no...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide NEXPLANON 68 MG IMPLANTS with a potential value of $6,837.40. This delivery order is issued against a larger indefinite delivery contract held by DMS Pharmaceutical Group with DLA Troop Support Medical to supply a variety of pharmaceutical and medical products, including specialized contraceptive items, in support of military treatment...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide NEXPLANON 68 mg implants. The contract has a potential value of $2,858.76 and a completion date of February 1, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds multiple federal contracts and Indefinite Delivery Vehicles (IDVs) to supply pharmaceuticals and medical products in...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide NEXPLANON 68 MG IMPLANTS. The contract has a potential value of $3,573.45 and a completion date of January 29, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds multiple federal contracts and indefinite delivery vehicles (IDVs) with DLA to supply a variety of pharmaceuticals and medical products to military...
- The Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide NEXPLANON 68 MG IMPLANTS. The contract has a potential value of $3,573.45 and a completion date of February 14, 2024. This delivery order is issued against a larger indefinite delivery contract between DMS Pharmaceutical Group and the Defense Logistics Agency to supply a variety of pharmaceutical and medical products to...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the provision of NEXPLANON 68 MG IMPLANTS. The $42,881.40 contract has an ultimate completion date of October 9, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC allows the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of NEXPLANON 68 MG IMPLANTS. The contract, valued at $8,576.28, has an ultimate completion date of July 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc., valued at up to $499,999,999, that allows the DLA to issue firm fixed-price delivery orders for a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 68 mg NEXPLANON contraceptive implants. The $14,293.80 order has a completion date of February 1, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple DLA contracts and indefinite delivery vehicles to supply a variety of medical items and pharmaceuticals to military treatment facilities worldwide. This...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed-price delivery order worth $3,573.45 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of NEXPLANON 68 MG IMPLANTS. This order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the DLA, valued up to $4,999,999 through 2025, which enables the agency to order a broad range of pharmaceutical products to support military health...
- SPE2DB22D9309Indefinite Delivery Contract
- SPE2DB22D9309-SPE2DB24FAE31Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide NEXPLANON 68 MG implants. The order has a completion date of January 30, 2024 and a potential value of $7,146.90. This delivery order is part of a larger indefinite delivery contract DMS Pharmaceutical Group holds with DLA Troop Support Medical to provide a variety of pharmaceutical items and medical supplies to support military treatment facilities worldwide. The contract does not have a set-aside designation.
Generated 4/8/24, 9:29 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 1/8/24 |